1-6 of 6
David R. Shalinsky
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Multicenter, Phase II Study of Axitinib, a Selective Second-Generation Inhibitor of Vascular Endothelial Growth Factor Receptors 1, 2, and 3, in Patients with Metastatic Melanoma

John Fruehauf, Jose Lutzky, David McDermott, Charles K. Brown, Jean-Baptiste Meric, Brad Rosbrook, David R. Shalinsky, Katherine F. Liau, Andreas G. Niethammer, Sinil Kim, Olivier Rixe
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (23): 7462–7469.
https://doi.org/10.1158/1078-0432.CCR-11-0534
Published: 30 November 2011
View articletitled, Multicenter, Phase II Study of Axitinib, a Selective Second-Generation Inhibitor of Vascular Endothelial Growth Factor Receptors 1, 2, and 3, in Patients with Metastatic Melanoma
Open the PDF for Multicenter, Phase II Study of Axitinib, a Selective Second-Generation Inhibitor of Vascular Endothelial Growth Factor Receptors 1, 2, and 3, in Patients with Metastatic Melanoma in another window
Journal Articles

Quantification of Circulating Endothelial Cells by Flow Cytometry

Patrizia Mancuso, Angelica Calleri, Francesco Bertolini, Carlo Tacchetti, John V. Heymach, David R. Shalinsky
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (10): 3640.
https://doi.org/10.1158/1078-0432.CCR-09-0591
Published: 18 May 2009
View articletitled, Quantification of Circulating Endothelial Cells by Flow Cytometry
Open the PDF for Quantification of Circulating Endothelial Cells by Flow Cytometry in another window
Journal Articles

Validation of a Standardized Method for Enumerating Circulating Endothelial Cells and Progenitors: Flow Cytometry and Molecular and Ultrastructural Analyses

Patrizia Mancuso, Pierluigi Antoniotti, Jessica Quarna, Angelica Calleri, Cristina Rabascio, Carlo Tacchetti, Paola Braidotti, Hua-Kang Wu, Amado J. Zurita, Luca Saronni, John B. Cheng, David R. Shalinsky, John V. Heymach, Francesco Bertolini
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (1): 267–273.
https://doi.org/10.1158/1078-0432.CCR-08-0432
Published: 31 December 2008
View articletitled, Validation of a Standardized Method for Enumerating Circulating Endothelial Cells and Progenitors: Flow Cytometry and Molecular and Ultrastructural Analyses
Open the PDF for Validation of a Standardized Method for Enumerating Circulating Endothelial Cells and Progenitors: Flow Cytometry and Molecular and Ultrastructural Analyses in another window
Journal Articles

Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 3

Dana D. Hu-Lowe, Helen Y. Zou, Maren L. Grazzini, Max E. Hallin, Grant R. Wickman, Karin Amundson, Jeffrey H. Chen, David A. Rewolinski, Shinji Yamazaki, Ellen Y. Wu, Michele A. McTigue, Brion W. Murray, Robert S. Kania, Patrick O'Connor, David R. Shalinsky, Steve L. Bender
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (22): 7272–7283.
https://doi.org/10.1158/1078-0432.CCR-08-0652
Published: 14 November 2008
View articletitled, Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 3
Open the PDF for Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 3 in another window
Includes: Supplementary data
Journal Articles

Blood-Based Biomarkers of SU11248 Activity and Clinical Outcome in Patients with Metastatic Imatinib-Resistant Gastrointestinal Stromal Tumor

Anat Norden-Zfoni, Jayesh Desai, Judith Manola, Paul Beaudry, Jeremy Force, Robert Maki, Judah Folkman, Carlo Bello, Charles Baum, Sam E. DePrimo, David R. Shalinsky, Goerge D. Demetri, John V. Heymach
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (9): 2643–2650.
https://doi.org/10.1158/1078-0432.CCR-06-0919
Published: 01 May 2007
View articletitled, Blood-Based Biomarkers of SU11248 Activity and Clinical Outcome in Patients with Metastatic Imatinib-Resistant Gastrointestinal Stromal Tumor
Open the PDF for Blood-Based Biomarkers of SU11248 Activity and Clinical Outcome in Patients with Metastatic Imatinib-Resistant Gastrointestinal Stromal Tumor in another window
Journal Articles

Marked Antiangiogenic and Antitumor Efficacy of AG3340 in Chemoresistant Human Non-Small Cell Lung Cancer Tumors: Single Agent and Combination Chemotherapy Studies

David R. Shalinsky, John Brekken, Helen Zou, Laura A. Bloom, Charles D. McDermott, Scott Zook, Nissi M. Varki, Krzysztof Appelt
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (7): 1905–1917.
Published: 01 July 1999
View articletitled, Marked Antiangiogenic and Antitumor Efficacy of AG3340 in Chemoresistant Human Non-Small Cell Lung Cancer Tumors: Single Agent and Combination Chemotherapy Studies
Open the PDF for Marked Antiangiogenic and Antitumor Efficacy of AG3340 in Chemoresistant Human Non-Small Cell Lung Cancer Tumors: Single Agent and Combination Chemotherapy Studies in another window